CA2191855A1 - Compositions pharmaceutiques solides contenant un principe actif a base d'acide (s)-2-(4-isobutylphenyle) propionique, ainsi qu'une cellulose microcristalline et une silice colloidale en tant qu'excipients - Google Patents

Compositions pharmaceutiques solides contenant un principe actif a base d'acide (s)-2-(4-isobutylphenyle) propionique, ainsi qu'une cellulose microcristalline et une silice colloidale en tant qu'excipients

Info

Publication number
CA2191855A1
CA2191855A1 CA002191855A CA2191855A CA2191855A1 CA 2191855 A1 CA2191855 A1 CA 2191855A1 CA 002191855 A CA002191855 A CA 002191855A CA 2191855 A CA2191855 A CA 2191855A CA 2191855 A1 CA2191855 A1 CA 2191855A1
Authority
CA
Canada
Prior art keywords
isobutylphenyl
active ingredient
propionic acid
excipients
solid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002191855A
Other languages
English (en)
Other versions
CA2191855C (fr
Inventor
Federico Stroppolo
Daniele Bonadeo
Alberto Pagano
Annibale Gazzaniga (Deceased)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Federico Stroppolo
Daniele Bonadeo
Alberto Pagano
Annibale Gazzaniga (Deceased)
Gazzaniga, Giovanni
Marabelli, Cisella
Zambon Group S.P.A.
Gazzaniga, Paolo
Zambon S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI941262A external-priority patent/IT1270239B/it
Application filed by Federico Stroppolo, Daniele Bonadeo, Alberto Pagano, Annibale Gazzaniga (Deceased), Gazzaniga, Giovanni, Marabelli, Cisella, Zambon Group S.P.A., Gazzaniga, Paolo, Zambon S.P.A. filed Critical Federico Stroppolo
Publication of CA2191855A1 publication Critical patent/CA2191855A1/fr
Application granted granted Critical
Publication of CA2191855C publication Critical patent/CA2191855C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
CA002191855A 1994-06-17 1995-05-26 Compositions pharmaceutiques solides contenant un principe actif a base d'acide (s)-2-(4-isobutylphenyle) propionique, ainsi qu'une cellulose microcristalline et une silice colloidale en tant qu'excipients Expired - Lifetime CA2191855C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI94A001262 1994-06-17
ITMI941262A IT1270239B (it) 1994-06-17 1994-06-17 Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
PCT/EP1995/002010 WO1995035104A1 (fr) 1994-06-17 1995-05-26 Compositions pharmaceutiques solides contenant un principe actif a base d'acide (s)-2-(4-isobutylphenyle) propionique, ainsi qu'une cellulose microcristalline et une silice colloidale en tant qu'excipients

Publications (2)

Publication Number Publication Date
CA2191855A1 true CA2191855A1 (fr) 1995-12-28
CA2191855C CA2191855C (fr) 2006-08-01

Family

ID=36764259

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002191855A Expired - Lifetime CA2191855C (fr) 1994-06-17 1995-05-26 Compositions pharmaceutiques solides contenant un principe actif a base d'acide (s)-2-(4-isobutylphenyle) propionique, ainsi qu'une cellulose microcristalline et une silice colloidale en tant qu'excipients

Country Status (1)

Country Link
CA (1) CA2191855C (fr)

Also Published As

Publication number Publication date
CA2191855C (fr) 2006-08-01

Similar Documents

Publication Publication Date Title
EP0264187B1 (fr) Composition pharmaceutique contenant de l'ibuprofen et de l'hydroxyde d'aluminium
CA2251886A1 (fr) Preparation pharmaceutique orale contenant de l'ibandronate
CA2258095A1 (fr) Compositions contenant de la tetrahydrolipstatine
CA2123160A1 (fr) Formulation a liberation controlee
CA2346988A1 (fr) Formulation pharmaceutique contenant de l'omeprazole
HRP20000142B1 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
CA2232310A1 (fr) Compositions stables contenant du n-propargyl-1-aminoindane
CA2306103A1 (fr) Nouvelle preparation de sulfonyluree a liberation controlee et a posologie unique
CA2232152A1 (fr) Forme galenique solide bioadhesive
CA2377299A1 (fr) Compositions pharmaceutiques orales a liberation regulee a base de mesalazine
CA2150945A1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofene et son procede de preparation
AU2616795A (en) Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients
AU5861499A (en) Agitation-independent pharmaceutical multiple unit retard preparations and method for the production thereof
AU4846690A (en) Polyunsaturated fatty acid derivatives, pharmaceutical compositions containing the same, method for the preparation thereof, and their use as medicament
RU97100851A (ru) Твердые фармацевтические композиции, содержащие (s)-2-(4- изобутилфенил)пропионовую кислоту в качестве активного ингредиента и микрокристаллическую целлюлозу и коллоидный оксид кремния в качестве эксципиентов
AU4560297A (en) Pharmaceutical microspheres of valproic acid for oral administration
CA2120048A1 (fr) Composition pharmaceutique ayant une activite analgesique
CA2255052A1 (fr) Preparation de derive de prostaglandine i a liberation prolongee
CA2255064A1 (fr) Formulations pharmaceutiques contenant du potassium, du sodium et des sels tris d'oxaprozine
CA2386423A1 (fr) Compositions pharmaceutiques et leur utilisation
CA2191855A1 (fr) Compositions pharmaceutiques solides contenant un principe actif a base d'acide (s)-2-(4-isobutylphenyle) propionique, ainsi qu'une cellulose microcristalline et une silice colloidale en tant qu'excipients
CA2193235A1 (fr) Preparation de comprimes a base d'acide fusidique
IE893502L (en) Formulations
GB2097389A (en) Oxazole derivative
CA2252394A1 (fr) Granules de cellulose hydrolysee pour produits pharmaceutiques

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150526